• Home
  • Technology
  • Gaming
  • Entertainment
  • World & Business
  • Science
  • Sports
  • AI
HomeTechnologyGamingEntertainmentWorld & BusinessScienceSportsAI
World & Business

Dozens sue GLP-1 drugmakers, alleging inadequate warnings about a rare type of sudden vision loss

ABC News reports that the personal injury lawsuits target makers of popular drugs including Ozempic, Wegovy and Mounjaro.

AN
TW
UT
7 Sources, 9d ago, first seen 9d ago

TLDR

ABC News reports that dozens of Americans have filed personal injury lawsuits against GLP-1 drugmakers. The plaintiffs claim they were not properly warned of the risk of a rare type of sudden vision loss when taking medications such as Ozempic, Wegovy and Mounjaro.

Combined views

906.4K

7 Sources, first seen 9d ago

1.3K likes136 comments420 saves547 reposts

Combined views

906.4K

7 Sources, first seen 9d ago

1.3K likes136 comments420 saves547 reposts

Sentiment

Positive——Negative

Summary

Not enough discussion yet.

No sentiment analysis available yet.

Sentiment

Positive——Negative

Summary

Not enough discussion yet.

No sentiment analysis available yet.

7 Sources

@ABCDozens of Americans have filed personal injury lawsuits against the makers of popular GLP-1 drugs — like Ozempic, Wegovy and Mounjaro — claiming they were not properly warned of the risk of a rare type of sudden vision loss when taking the medications. https://abcnews.link/kzZ2Nr7
@WSJPatients are suing GLP-1 drugmakers over the risk of sudden vision loss. The little-discussed potential risk of popular diabetes and weight-loss drugs is on warning labels outside of the U.S. https://on.wsj.com/4yMSegF
@USATODAYGLP-1 makers Eli Lilly and Novo Nordisk have been the subject of thousands of lawsuits alleging injury. Those related to vision loss are the latest to pile up. https://www.usatoday.com/story/news/health/2026/09/21/glp-1-blindness-lawsuits-rare-cases/91877381007/?taid=6ab1ebb5bdab4800016119d2&utm_campaign=trueanthem&utm_medium=social&utm_source=twitter
@AJEnglishDozens of people have filed lawsuits in the US against GLP-1 companies, which make popular weight-loss drugs like Ozempic and Mounjaro, claiming their products caused a rare condition that can cause permanent vision loss. Read more here: https://aje.news/tqdk6e
  • HomeTechnologyGamingEntertainmentWorld & BusinessScienceSportsAI
    • Home
    • Technology
    • Gaming
    • Entertainment
    • World & Business
    • Science
    • Sports
    • AI

    7 Sources

    @ABCDozens of Americans have filed personal injury lawsuits against the makers of popular GLP-1 drugs — like Ozempic, Wegovy and Mounjaro — claiming they were not properly warned of the risk of a rare type of sudden vision loss when taking the medications. https://abcnews.link/kzZ2Nr7
    @WSJPatients are suing GLP-1 drugmakers over the risk of sudden vision loss. The little-discussed potential risk of popular diabetes and weight-loss drugs is on warning labels outside of the U.S. https://on.wsj.com/4yMSegF
    @USATODAYGLP-1 makers Eli Lilly and Novo Nordisk have been the subject of thousands of lawsuits alleging injury. Those related to vision loss are the latest to pile up. https://www.usatoday.com/story/news/health/2026/09/21/glp-1-blindness-lawsuits-rare-cases/91877381007/?taid=6ab1ebb5bdab4800016119d2&utm_campaign=trueanthem&utm_medium=social&utm_source=twitter
    @AJEnglishDozens of people have filed lawsuits in the US against GLP-1 companies, which make popular weight-loss drugs like Ozempic and Mounjaro, claiming their products caused a rare condition that can cause permanent vision loss. Read more here: https://aje.news/tqdk6e
    Today's Rank

    —

    Not ranked yet

    Today's Rank

    —

    Not ranked yet